Early Access

10-KPeriod: FY2007

HONEYWELL INTERNATIONAL INC Annual Report, Year Ended Dec 31, 2007

Filed February 15, 2008For Securities:HON

Summary

Honeywell International Inc.'s 2007 Form 10-K filing reveals a company with robust sales growth and strong performance across its diverse segments. Net sales increased by 10% to $34.6 billion, driven by growth in Aerospace and Automation and Control Solutions (ACS). The company demonstrated improved profitability, with income from continuing operations rising to $2.44 billion, a 17.6% increase year-over-year. This growth was supported by higher gross margins, effective cost management (as SG&A as a percentage of sales decreased), and strategic acquisitions. Financially, Honeywell maintained a strong liquidity position, with significant operating cash flow and a substantial backlog of $12.3 billion. The company continued its commitment to returning value to shareholders through share repurchases, having bought back approximately $3.9 billion in shares during 2007. While facing industry-specific challenges and risks such as raw material price volatility and international operational risks, Honeywell appears well-positioned due to its diversified business model and focus on innovation and cost efficiency.

Key Highlights

  • 1Net sales grew by 10% to $34.6 billion in 2007, driven by strong performance in Aerospace and Automation and Control Solutions (ACS).
  • 2Income from continuing operations increased by 17.6% to $2.44 billion, leading to diluted EPS of $3.16.
  • 3Gross margin improved to 24.0% from 23.2% in the prior year, attributed to higher margins in Specialty Materials and Aerospace, and lower pension expenses.
  • 4Selling, general, and administrative (SG&A) expenses as a percentage of sales decreased slightly to 13.2% from 13.4%, indicating improved cost efficiency.
  • 5The company's total backlog stood at $12.3 billion at year-end 2007, indicating a strong pipeline of future business.
  • 6Honeywell repurchased $3.99 billion of its common stock in 2007 under its authorized share repurchase program, demonstrating a commitment to shareholder returns.
  • 7Significant investments in R&D continued, with R&D expenses totaling $1.46 billion, up 3% from the prior year, supporting innovation across segments.

Frequently Asked Questions